跳至主要内容
临床试验/ISRCTN39503939
ISRCTN39503939已完成不适用

A prospective, randomised, controlled evaluation of the effects of optimisation of cerebral oxygenation and depth of anaesthesia on postoperative cognitive functioning in older patients undergoing major orthopaedic and abdominal surgery

King's College London (UK)0 个研究点目标入组 250 人开始时间: 2006年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 65 years or over
  • 2. Due to undergo major abdominal or orthopaedic surgery or a healthy relative of such a patient
  • 3. Able to give informed consent
  • 4. Fluency in English

排除标准

  • 1. Mild cognitive impairment
  • 2. Dementia
  • 3. Physical disability which would interfere with cognitive interviewing (blindness, inability to write)

研究者

发起方
King's College London (UK)

相似试验

已完成
不适用
A prospective, randomised, controlled Study evaluating the effect of waterfiltered infrared A radiation (wIRA) on wound healing of venous leg ulcersI83.2Varicose veins of lower extremities with both ulcer and inflammation
DRKS00000669niversitäts-Hautklinik51
招募中
4 期
Prospective randomized and controlled evaluation of immunological parameters at teeth, zirconia ceramic implants and titanium implants with split-mouth design in humansK05.6Periodontal disease, unspecified
DRKS00026140Oral Reconstruction Foundation20
终止
不适用
Tongue injury among patients with epilepsy undergoing video-encephalographic monitoring
ACTRN12620001022954Royal Prince Alfred Hospital5
已完成
不适用
A prospective, randomized controlled trial assessing the efficacy and safety of cilostazol and aspirin therapy versus aspirin therapy for the prevention of vascular events in patietns undergoing coronary stent implantatio
JPRN-UMIN000012541Koseikai Takai Hospital700
进行中(未招募)
1 期
prospective, randomized, controlled study evaluating the effect of conversion from tacrolimus treatment to mTor inhibitor-based immunosuppression + tacrolimus to boost conversion to positive SARS-CoV-2 serology after a fourth dose of the vaccine of SARS-CoV-2 mRNA in solid organ transplant recipients who have not previously responded.Seroconversion is evaluated after changing treatment from tacrolimus to tacrolimus + mTOR inhibitor in solid organ transplant patients who have not responded to the first three doses of the vaccineMedDRA version: 21.0Level: PTClassification code 10080575Term: Solid organ transplantSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2022-000617-13-ESFundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)50
A prospective, randomised, controlled evaluation of... | 临床试验